SEC Filing Summary
Filing identity: The supplied filing is Nanometrics Incorporated’s Form 10-Q for the quarter ended September 29, 2012—not an Onto Innovation filing for 2010 Q3 as indicated in the request metadata. Financial statements are unaudited.
Business context and reporting period
Nanometrics designed and sold process-control metrology and inspection systems used primarily in semiconductor manufacturing, as well as in LED, solar, wafer and data-storage markets. The filing reports the three- and nine-month periods ended September 29, 2012, compared with periods ended October 1, 2011.
Financial performance
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Revenue | $43.9 million | $58.3 million | $152.6 million | $184.8 million |
| Gross profit | $22.2 million | $30.6 million | $72.0 million | $101.4 million |
| Operating income | $3.6 million | $11.7 million | $12.0 million | $46.3 million |
| Net income | $1.9 million | $7.6 million | $8.1 million | $29.2 million |
| Diluted EPS | $0.08 | $0.32 | $0.34 | $1.24 |
- Q3 gross margin was approximately 50.4%, versus 52.5% a year earlier; nine-month gross margin was approximately 47.2%, versus 54.9%. Q3 operating margin was approximately 8.2%, versus 20.2%.
- Product revenue declined 35.2% in Q3 and 23.0% for the first nine months year over year. Service revenue rose 37.9% and 15.5%, respectively.
- For the nine months, operating cash flow was $12.8 million, down from $35.4 million. Investing used $40.6 million, primarily for net purchases of marketable securities; financing used $2.8 million, including $5.0 million of share repurchases and $2.0 million of debt repayments.
- At September 29, cash and cash equivalents were $67.5 million and marketable securities were $37.3 million, totaling $104.8 million. Working capital was $165.1 million. Total debt was $5.5 million; the company had no balance drawn on its revolving credit facility, with $16.0 million available.
Material changes and management commentary
- Management attributed weaker product sales primarily to a slowdown in industry spending. Automated systems revenue fell 21.0% in Q3; integrated systems fell 64.7%, including lower demand for legacy 9010 products; materials-characterization revenue fell 64.5%, reflecting reduced FTIR and RPM demand amid excess HB-LED capacity and limited bare-wafer market expansion.
- Product margins were pressured by higher Atlas II production costs, reduced factory absorption from lower production volume, product mix, and additional amortization related to the Nanda acquisition. Service margin improved, principally from higher-margin upgrades.
- Research and development spending increased 18.7% in Q3 and 28.8% for the nine months, reflecting development activity, equipment costs and staffing, including Nanda-related costs.
- Management said cash, securities and borrowing availability should be sufficient for at least the next twelve months, while noting that performance and liquidity depend on operating results and economic conditions. No specific revenue or earnings guidance was provided.
Risks, contingencies and unusual items
- Key disclosed exposures include semiconductor-industry spending and customer demand, product mix and shipment timing, supply-chain flexibility, new-product adoption, and foreign-exchange and interest-rate movements. Revenue and receivables were concentrated among major customers; Samsung, Intel, SK Hynix and TSMC each represented at least 10% of Q3 revenue.
- The company maintained a valuation allowance on certain deferred tax assets because of uncertainty about future taxable income. A $1.4 million discrete tax benefit from IRS-approved tax elections affected the nine-month tax provision.
- A $2.5 million KLA settlement payment was made in Q1 2012; the charge had been recorded in Q4 2011. Acquisition-related contingent consideration was $2.7 million at quarter-end and is measured using significant unobservable inputs.
- The filing reported no legal proceedings and no material change to previously disclosed risk factors except for added discussion of supply-chain management and effective tax-rate fluctuations. Management reported disclosure controls were effective; no material internal-control changes occurred during the quarter.
Important facts for investors to verify
- Confirm the intended issuer and period: the filing is Nanometrics Incorporated, Q3 2012, despite the Onto Innovation/2010 Q3 metadata.
- Assess whether weaker product demand and lower factory utilization persisted beyond this quarter, especially in integrated and materials-characterization systems.
- Monitor product margins, Atlas II costs, R&D spending and the extent to which service upgrades offset system revenue declines.
- Review customer concentration, deferred tax asset realizability, acquisition-related obligations, and the terms and availability of the credit facility.
- Distinguish cash-flow generation from investment portfolio purchases: the large investing outflow primarily moved funds into marketable securities rather than representing operating expenditure.